James W. Korfhage
Gründer bei Oregon Life Sciences LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| James Hicks | M | 77 |
Virogenomics BioDevelopment, Inc.
 Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 Jahre |
| Jeff King | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 Jahre |
| Brock Metcalf | M | - |
Oregon Life Sciences LLC
 Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon.
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
| Renee Shirley | F | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 Jahre |
| Gilbert N. Miller | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
| Llew Keltner | M | 74 |
Oregon Life Sciences LLC
Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | - |
| Rob Wiltbank | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
| William Newman | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| C. Jespersen | M | 78 |
University of Oregon
| 5 Jahre |
| Eric David Lawson | M | 79 |
University of Oregon
| 5 Jahre |
| Timothy Boyle | M | 73 |
University of Oregon
| 4 Jahre |
| Hartmut Baitis | M | 74 |
University of Oregon
| 4 Jahre |
| Ronald Horne | M | 79 |
University of Oregon
| 4 Jahre |
| Gordon T. Frost | M | - |
University of Oregon
| 4 Jahre |
| Jan Sieberts | M | - |
University of Oregon
| 4 Jahre |
| David Lippoff | M | - |
University of Oregon
| 4 Jahre |
| Tony Keller | M | - |
University of Oregon
| 1 Jahre |
| Thomas Wikstrom | M | 76 |
University of Oregon
| 4 Jahre |
| Richard L. Fletcher | M | 84 |
University of Oregon
| - |
| Carlton Cadwell | M | 79 |
University of Oregon
| 4 Jahre |
| Jim Jones | M | 82 |
University of Oregon
| - |
| Bill McCorriston | M | - |
University of Oregon
| 4 Jahre |
| Choung Kim | M | - |
University of Oregon
| 3 Jahre |
| Mary Cameron | F | - |
University of Oregon
| 4 Jahre |
| Jim Jones | M | - |
University of Oregon
| 3 Jahre |
| Dennis Ciocca | M | - |
University of Oregon
| 2 Jahre |
| Dan W. Hollingshead | M | - |
University of Oregon
| 4 Jahre |
| Omar Ziad Jaafar Al-Askari | M | - |
University of Oregon
| 4 Jahre |
| John T. Lemley | M | - |
University of Oregon
| 2 Jahre |
| René Olivieri | M | - |
University of Oregon
| 4 Jahre |
| Celia H. Currin | F | 76 |
University of Oregon
| 4 Jahre |
| Michael B. Wilkes | M | - |
University of Oregon
| 4 Jahre |
| Kenneth S. Beat | M | - |
University of Oregon
| 4 Jahre |
| Richard D. Fulmer | M | 78 |
University of Oregon
| 4 Jahre |
| Greg Houser | M | 76 |
University of Oregon
| 4 Jahre |
| Charles Craig Seven | M | 80 |
University of Oregon
| 4 Jahre |
| Peter Johnson | M | - |
University of Oregon
| 4 Jahre |
| James E. Crabbe | M | 78 |
University of Oregon
| 4 Jahre |
| Mary Modesta Bersot | F | - |
University of Oregon
| 4 Jahre |
| Richard E. Hanson | M | 80 |
University of Oregon
| 4 Jahre |
| Dana Siebert | M | - |
Oregon Life Sciences LLC
Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | - |
| David A. G. Bending | M | 70 |
University of Oregon
| 4 Jahre |
| Dan McPhun | M | - |
University of Oregon
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 43 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- James W. Korfhage
- Persönliches Netzwerk
